Atai Life Sciences Stock Performance
| ATAI Stock | USD 1.97 0.10 5.35% |
On a scale of 0 to 100, ATAI Life holds a performance score of 4. The firm owns a Beta (Systematic Risk) of 2.52, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, ATAI Life will likely underperform. Please check ATAI Life's sortino ratio, semi variance, and the relationship between the information ratio and value at risk , to make a quick decision on whether ATAI Life's current price history will revert.
Risk-Adjusted Performance
4 of 100
Weak | Strong |
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in ATAI Life Sciences are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, ATAI Life demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
1 | Atai Life Sciences names Anne Johnson as its CFO | 02/06/2024 |
2 | Acquisition by Rao Srinivas of 800000 shares of ATAI Life at 1.84 subject to Rule 16b-3 | 03/13/2024 |
3 | Acquisition by Gutierrez-esteinou Rolando of 500000 shares of ATAI Life at 1.18 subject to Rule 16b-3 | 03/20/2024 |
4 | Disposition of 200000 shares by Anne Johnson of ATAI Life subject to Rule 16b-3 | 03/26/2024 |
5 | atai Life Sciences Announces Positive Initial Results from Beckley Psytechs Phase 2a Open Label Study of BPL-003 in Treatment Resistant Depression | 03/27/2024 |
6 | atai Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate and Clinical Highlights | 03/28/2024 |
7 | Disposition of 35801 shares by Kirpekar Sahil of ATAI Life at 1.85 subject to Rule 16b-3 | 04/02/2024 |
8 | Atai Life Sciences CFO sells 50,708 in company stock | 04/04/2024 |
9 | ATA Creativity Global Announces Filing of Annual Report on Form 20-F for the Year Ended December 31, 2023 | 04/10/2024 |
10 | Disposition of 147950 shares by Apeiron Investment Group Ltd. of ATAI Life subject to Rule 16b-3 | 04/15/2024 |
11 | atai Life Sciences reports positive Phase 1 results for BPL-003 | 04/17/2024 |
12 | Jim Cramer Slams Political Blocking Of LSD-Derived Antidepressants, Citing Strong Test Data Showing They Worked | 04/19/2024 |
| Begin Period Cash Flow | 190.6 M |
ATAI |
ATAI Life Relative Risk vs. Return Landscape
If you would invest 174.00 in ATAI Life Sciences on January 25, 2024 and sell it today you would earn a total of 23.00 from holding ATAI Life Sciences or generate 13.22% return on investment over 90 days. ATAI Life Sciences is currently generating 0.3839% in daily expected returns and assumes 6.2776% risk (volatility on return distribution) over the 90 days horizon. In different words, 55% of stocks are less volatile than ATAI, and 93% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
ATAI Life Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ATAI Life's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ATAI Life Sciences, and traders can use it to determine the average amount a ATAI Life's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0612
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ATAI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 6.28 actual daily | 55 55% of assets are less volatile |
Expected Return
| 0.38 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average ATAI Life is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ATAI Life by adding it to a well-diversified portfolio.
ATAI Life Fundamentals Growth
ATAI Stock prices reflect investors' perceptions of the future prospects and financial health of ATAI Life, and ATAI Life fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ATAI Stock performance.
| Return On Equity | -0.17 | ||||
| Return On Asset | -0.26 | ||||
| Current Valuation | 154.11 M | ||||
| Shares Outstanding | 166.03 M | ||||
| Price To Earning | 0.30 X | ||||
| Price To Book | 1.57 X | ||||
| Price To Sales | 1,216 X | ||||
| Revenue | 314 K | ||||
| Gross Profit | 233 K | ||||
| EBITDA | (125.15 M) | ||||
| Net Income | (40.22 M) | ||||
| Cash And Equivalents | 304.06 M | ||||
| Cash Per Share | 1.83 X | ||||
| Total Debt | 16.48 M | ||||
| Debt To Equity | 0.06 % | ||||
| Current Ratio | 12.25 X | ||||
| Book Value Per Share | 1.46 X | ||||
| Cash Flow From Operations | (84.12 M) | ||||
| Earnings Per Share | (0.25) X | ||||
| Market Capitalization | 310.47 M | ||||
| Total Asset | 293.48 M | ||||
| Retained Earnings | (550.94 M) | ||||
| Working Capital | 165.47 M | ||||
| Current Asset | 320.15 M | ||||
| Current Liabilities | 74.35 M | ||||
About ATAI Life Performance
To evaluate ATAI Life Sciences Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when ATAI Life generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare ATAI Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand ATAI Life Sciences market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents ATAI's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0 | 0 | |
| Return On Tangible Assets | (0.14) | (0.14) | |
| Return On Capital Employed | (0.46) | (0.48) | |
| Return On Assets | (0.14) | (0.14) | |
| Return On Equity | (0.17) | (0.17) |
Things to note about ATAI Life Sciences performance evaluation
Checking the ongoing alerts about ATAI Life for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ATAI Life Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ATAI Life Sciences had very high historical volatility over the last 90 days | |
| ATAI Life Sciences may become a speculative penny stock | |
| The company reported the previous year's revenue of 314 K. Net Loss for the year was (40.22 M) with profit before overhead, payroll, taxes, and interest of 233 K. | |
| ATAI Life Sciences currently holds about 304.06 M in cash with (84.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83. | |
| ATAI Life Sciences has a frail financial position based on the latest SEC disclosures | |
| Latest headline from benzinga.com: Jim Cramer Slams Political Blocking Of LSD-Derived Antidepressants, Citing Strong Test Data Showing They Worked |
- Analyzing ATAI Life's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ATAI Life's stock is overvalued or undervalued compared to its peers.
- Examining ATAI Life's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ATAI Life's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ATAI Life's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ATAI Life's stock. These opinions can provide insight into ATAI Life's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ATAI Life Sciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the ATAI Life Sciences information on this page should be used as a complementary analysis to other ATAI Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for ATAI Stock analysis
When running ATAI Life's price analysis, check to measure ATAI Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ATAI Life is operating at the current time. Most of ATAI Life's value examination focuses on studying past and present price action to predict the probability of ATAI Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ATAI Life's price. Additionally, you may evaluate how the addition of ATAI Life to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |
Is ATAI Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ATAI Life. If investors know ATAI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ATAI Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.97) | Earnings Share (0.25) | Revenue Per Share 0.002 | Quarterly Revenue Growth (0.53) | Return On Assets (0.26) |
The market value of ATAI Life Sciences is measured differently than its book value, which is the value of ATAI that is recorded on the company's balance sheet. Investors also form their own opinion of ATAI Life's value that differs from its market value or its book value, called intrinsic value, which is ATAI Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ATAI Life's market value can be influenced by many factors that don't directly affect ATAI Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ATAI Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ATAI Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ATAI Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.